<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Sartorius on Bioecon</title><link>https://en.bioecon.ru/companies/sartorius/</link><description>Recent content in Sartorius on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Mon, 27 Jul 2026 10:55:47 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/sartorius/index.xml" rel="self" type="application/rss+xml"/><item><title>Microcarriers for adherent cell cultures</title><link>https://en.bioecon.ru/technology/microcarriers-adherent-cell-culture/</link><pubDate>Sat, 25 Jul 2026 20:30:33 +0000</pubDate><guid>https://en.bioecon.ru/technology/microcarriers-adherent-cell-culture/</guid><description>Small (100–300 μm) suspended particles whose surface lets anchorage-dependent cells grow inside ordinary stirred-tank and single-use bioreactors — the consumable that turns adherent biology (vaccines, cell therapy, cultivated meat) into a scalable, GMP industrial process.</description></item><item><title>Single-use bag bioreactors (50L-2000L)</title><link>https://en.bioecon.ru/technology/single-use-bag-bioreactors-50l-2000l/</link><pubDate>Fri, 24 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/single-use-bag-bioreactors-50l-2000l/</guid><description>Gamma-irradiated single-use bag bioreactors in the 50-2000 L stirred-tank class — Sartorius Biostat STR, Cytiva Xcellerex XDR, Thermo Fisher HyPerforma, Merck Mobius — that replaced stainless steel for clinical and commercial mAb, vaccine and cell-and-gene-therapy manufacturing, cutting facility build-out from years to weeks and underpinning the CDMO economy.</description></item><item><title>Mini-bioreactors for DOE screening</title><link>https://en.bioecon.ru/technology/mini-bioreactors-doe-screening/</link><pubDate>Thu, 23 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/mini-bioreactors-doe-screening/</guid><description>Automated mini- and micro-bioreactors (1-250 mL) running 24-48 cultures in parallel that map a bioprocess Design Space in days rather than months — the high-throughput on-ramp to cell-line, strain and upstream-process development, led by the German ambr, BioLector and DASbox platforms.</description></item><item><title>Process validation and qualification (CRO)</title><link>https://en.bioecon.ru/technology/process-validation-qualification-cro/</link><pubDate>Mon, 06 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/process-validation-qualification-cro/</guid><description>CRO-delivered three-stage process validation and IQ/OQ/PQ qualification of biopharma equipment — media fills, cleaning validation, CSV and viral clearance under FDA/EudraLex Annex 1 cGMP.</description></item><item><title>Single-use assemblies</title><link>https://en.bioecon.ru/technology/single-use-assemblies/</link><pubDate>Wed, 24 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/single-use-assemblies/</guid><description>Pre-sterilized, fully integrated polymer fluid paths and containment bags that eliminate cross-contamination, bypass intensive cleaning validation, and drastically compress biomanufacturing facility footprints.</description></item><item><title>Bioprocess analytics &amp; PAT (process analytical technology)</title><link>https://en.bioecon.ru/technology/bioprocess-analytics-pat/</link><pubDate>Mon, 22 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/bioprocess-analytics-pat/</guid><description>In-line sensing, chromatography and mass spectrometry that turn biomanufacturing into data-driven, feedback-controlled production — a stack from probe to real-time release.</description></item><item><title>Downstream Purification &amp; Bioseparation</title><link>https://en.bioecon.ru/technology/downstream-purification-bioseparation/</link><pubDate>Fri, 19 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/downstream-purification-bioseparation/</guid><description>Downstream purification converts crude bioreactor harvests into clinical-grade drug substance — chromatography (Protein A, IEX, HIC), tangential-flow filtration, and viral clearance together account for &amp;gt;50% of biomanufacturing CAPEX. The global DSP market exceeds $5B and grows at &amp;gt;8% CAGR driven by mAb and cell-gene therapy demand.</description></item><item><title>Single-use bioprocessing &amp; modular factories</title><link>https://en.bioecon.ru/technology/single-use-bioprocessing/</link><pubDate>Thu, 18 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/single-use-bioprocessing/</guid><description>Disposable bioreactors, bags and tubing plus modular factories (KUBio — 12–18 months vs 5–7 years) cut capex and cross-contamination, making biomanufacturing flexible and multi-product.</description></item></channel></rss>